These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28337768)

  • 1. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
    Schwartz FH; Cai Q; Fellmann E; Hartmann S; Mäyränpää MI; Karjalainen-Lindsberg ML; Sundström C; Scholtysik R; Hansmann ML; Küppers R
    J Pathol; 2017 Jun; 242(2):129-133. PubMed ID: 28337768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells.
    Lemonnier F; Mak TW
    J Pathol; 2017 Aug; 242(4):387-390. PubMed ID: 28543514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.
    Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ
    Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
    Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
    Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
    Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
    Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
    Wang M; Zhang S; Chuang SS; Ashton-Key M; Ochoa E; Bolli N; Vassiliou G; Gao Z; Du MQ
    Oncotarget; 2017 Mar; 8(11):17763-17770. PubMed ID: 28148900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
    Fukumoto K; Nguyen TB; Chiba S; Sakata-Yanagimoto M
    Cancer Sci; 2018 Mar; 109(3):490-496. PubMed ID: 28889481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
    Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
    Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type.
    Harland L; Borgmann V; Otto F; Overkamp M; Bonzheim I; Fend F; Quintanilla-Martinez L; Nann D
    Mod Pathol; 2024 Jul; 37(7):100519. PubMed ID: 38777036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.
    Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
    Odejide O; Weigert O; Lane AA; Toscano D; Lunning MA; Kopp N; Kim S; van Bodegom D; Bolla S; Schatz JH; Teruya-Feldstein J; Hochberg E; Louissaint A; Dorfman D; Stevenson K; Rodig SJ; Piccaluga PP; Jacobsen E; Pileri SA; Harris NL; Ferrero S; Inghirami G; Horwitz SM; Weinstock DM
    Blood; 2014 Feb; 123(9):1293-6. PubMed ID: 24345752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.
    Cairns RA; Iqbal J; Lemonnier F; Kucuk C; de Leval L; Jais JP; Parrens M; Martin A; Xerri L; Brousset P; Chan LC; Chan WC; Gaulard P; Mak TW
    Blood; 2012 Feb; 119(8):1901-3. PubMed ID: 22215888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
    Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
    Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
    Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
    Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT3A
    Zheng J; Wang Z; Pan X; Zhang Z; Li H; Deng X; Liu P; Zhang Q; Na F; Chen C; Niu T; Liu Y
    Oncogene; 2023 Jun; 42(23):1940-1950. PubMed ID: 37127775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordant intracellular and plasma D-2-hydroxyglutarate levels in a patient with IDH2 mutated angioimmunoblastic T-cell lymphoma.
    Churchill H; Naina H; Boriack R; Rakheja D; Chen W
    Int J Clin Exp Pathol; 2015; 8(9):11753-9. PubMed ID: 26617922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
    Wang C; McKeithan TW; Gong Q; Zhang W; Bouska A; Rosenwald A; Gascoyne RD; Wu X; Wang J; Muhammad Z; Jiang B; Rohr J; Cannon A; Steidl C; Fu K; Li Y; Hung S; Weisenburger DD; Greiner TC; Smith L; Ott G; Rogan EG; Staudt LM; Vose J; Iqbal J; Chan WC
    Blood; 2015 Oct; 126(15):1741-52. PubMed ID: 26268241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological characteristics of angioimmunoblastic T-cell lymphoma with B-cell proliferation or neoplasms].
    Li QM; Xu WL; Wu G; Li SH; Peng TS
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):660-666. PubMed ID: 38955695
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
    Sakata-Yanagimoto M; Nakamoto-Matsubara R; Komori D; Nguyen TB; Hattori K; Nanmoku T; Kato T; Kurita N; Yokoyama Y; Obara N; Hasegawa Y; Shinagawa A; Chiba S
    Ann Hematol; 2017 Sep; 96(9):1471-1475. PubMed ID: 28634614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.